Table 4. Systematic review inclusion, feasibility, and pragmatism in clinical trials.
| Characteristic | N=248 |
|---|---|
| Prior systematic review, n (%) | |
| Systematic review is cited | 192.0 (77.4) |
| Not cited or performed | 56.0 (22.6) |
| Non-feasibility reason, n (%) | |
| Study was feasible | 192.0 (77.4) |
| No reason provided | 44.0 (17.7) |
| Attrition | 7.0 (2.8) |
| Low recruitment speed | 5.0 (2.0) |
| Pragmatism violation*, n (%) | |
| Single-centered trial | 220.0 (88.7) |
| Blinding of assessors | 185.0 (74.6) |
| Placebo-controlled | 45.0 (18.1) |
| No pragmatism violation | 12.0 (4.8) |
One study had two pragmatism violations, resulting in a total N=462 for this section.